A detailed history of Catalina Capital Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Catalina Capital Group, LLC holds 4,282 shares of LLY stock, worth $3.63 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
4,282
Previous 3,928 9.01%
Holding current value
$3.63 Million
Previous $3.56 Billion 6.68%
% of portfolio
1.27%
Previous 1.34%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$772.14 - $960.02 $273,337 - $339,847
354 Added 9.01%
4,282 $3.79 Billion
Q2 2024

Jul 24, 2024

BUY
$724.87 - $909.04 $210,212 - $263,621
290 Added 7.97%
3,928 $3.56 Billion
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $1 Million - $1.34 Million
1,694 Added 87.14%
3,638 $2.83 Billion
Q4 2023

Apr 30, 2024

BUY
$525.19 - $619.13 $1.02 Million - $1.2 Million
1,944 New
1,944 $1.13 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Catalina Capital Group, LLC Portfolio

Follow Catalina Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalina Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalina Capital Group, LLC with notifications on news.